Lenalidomide

The combination of venetoclax…
Read More...

Elana Gotkine WEDNESDAY, Feb. 1, 2023 (HealthDay News) -- For patients with newly…
Read More...

Use of a triple-drug…
Read More...

Data from a large phase III trial…
Read More...

The open-label, randomized, crossover, ascending dose study will assess STAR-LLD safety, tolerability, and…
Read More...

For patients with newly diagnosed multiple myeloma there are…
Read More...

Consolidation treatment…
Read More...

PrSandoz® Lenalidomide is approved for the same indications as the reference medicine PrRevlimid®.PrSandoz®…
Read More...

PrSandoz® Lenalidomide est approuvé pour les mêmes indications que le médicament de référence PrRevlimid®.La…
Read More...